Global Healthcare Study on Hidradenitis Suppurativa
NCT07659769 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 9600
Last updated 2026-06-22
Summary
The Global Healthcare Study on Hidradenitis Suppurativa (GHSHS) is an international, multicenter observational study hosted by the University of Zurich (UZH) investigating healthcare access, treatment patterns, disease severity, and quality of life in patients with psoriasis. The study collects standardized clinical data from routine medical records to identify disparities in healthcare delivery and outcomes across different healthcare systems.
Conditions
- Hidradenitis Suppurativa (HS)
- Hidradenitis Suppurativa (Acne Inversa)
Sponsors & Collaborators
-
University of Zurich
collaborator OTHER -
University Hospital, Zürich
collaborator OTHER -
Julia Tatjana Maul
lead OTHER
Principal Investigators
-
Julia-Tatjana Maul, Prof. Dr. med. · University of Zurich
Eligibility
- Min Age
- 14 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-01-01
- Primary Completion
- 2029-12-31
- Completion
- 2029-12-31
Countries
- Switzerland
Study Locations
More Related Trials
-
A Double-blind Placebo-controlled Randomized Trial Evaluating the Efficacy and Safety of a Novel HSP90 Inhibitor (RGRN-305) in the Treatment of Moderate to Severe Hidradenitis Supppurativa.
NCT05286567 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Secukinumab in Conjunction With Surgery in Moderate to Severe Hidradenitis Suppurativa
NCT06926192 ·Status: RECRUITING
-
Secukinumab Treatment for Moderate to Severe Hidradenitis Suppurativa
NCT07109765 ·Status: RECRUITING
-
A Global Study Comparing Risankizumab to Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
NCT03926169 ·Status: COMPLETED ·Phase: PHASE2
-
A 24-Week Real-World Study of Upadacitinib in Moderate-to-Severe Hidradenitis Suppurativa
NCT07727889 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Study of Efficacy and Safety of Two Secukinumab Dose Regimens in Subjects With Moderate to Severe Hidradenitis Suppurativa (HS)
NCT03713632 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Long-Term Safety and Efficacy of Povorcitinib in Participants With Moderate to Severe Hidradenitis Suppurativa
NCT06212999 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis Suppurativa
NCT05620823 ·Status: COMPLETED ·Phase: PHASE3
-
Patients With Hidradenitis vs Patients With Psoriasis: Psychological Impact
NCT02999698 ·Status: UNKNOWN
-
A Proof of Concept Study to Evaluate the Effectiveness of Ustekinumab in Hidradenitis Suppurativa
NCT01704534 ·Status: COMPLETED ·Phase: PHASE2
-
Long Term Observational Study to Collect in a Real-world populatIon Data on the Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe HS Within the Italian Population
NCT07543419 ·Status: RECRUITING
-
Long Term Observational Study to Collect in a Real-world populatIon Data on the Treatment Pattern of secukinumAb in Adult Patients With Moderate to Severe Hidradenitis Suppurativa.
NCT05921994 ·Status: ACTIVE_NOT_RECRUITING
-
A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
NCT07225569 ·Status: RECRUITING ·Phase: PHASE2
-
Study of Single Doses of SBT777101 in Subjects With Hidradenitis Suppurativa
NCT06361836 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Etanercept in Hidradenitis Suppurativa
NCT00329823 ·Status: COMPLETED ·Phase: PHASE2
-
Effectiveness of Adalimumab in Moderate to Severe HidrAdenitis SuppuRativa Patients - a Multi cOuNtry studY in Real Life Setting
NCT02786576 ·Status: COMPLETED
-
A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa
NCT06840392 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Efficacy and Safety Study of IFX-1 in Patients With Moderate to Severe Hidradenitis Suppurativa (HS)
NCT03487276 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis Suppurativa (HS)
NCT05620836 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Hidradenitis Suppurativa
NCT04762277 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa (RECHARGE 1)
NCT06799000 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A National Registry For Patients With Hidradenitis Suppurativa
NCT03289585 ·Status: COMPLETED
-
A Phase 2 Study to Evaluate the Efficacy and Safety of SAR444656 Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
NCT06028230 ·Status: TERMINATED ·Phase: PHASE2
-
A Worldwide Survey on the Understanding of Psoriatic Disease Among Patients With Psoriasis and Psoriatic Arthritis
NCT04614831 ·Status: COMPLETED
-
This Was a Study of Efficacy and Safety of Two Secukinumab Dose Regimens in Subjects With Moderate to Severe Hidradenitis Suppurativa (HS).
NCT03713619 ·Status: COMPLETED ·Phase: PHASE3